X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare with Sterling Biotech - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs STERLING BIOTECH - Comparison Results

STERLING BIOTECH 
   Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES STERLING BIOTECH ALKEM LABORATORIES/
STERLING BIOTECH
 
P/E (TTM) x - -1.8 - View Chart
P/BV x 6.1 0.1 8,949.0% View Chart
Dividend Yield % 0.7 0.0 -  

Financials

 ALKEM LABORATORIES   STERLING BIOTECH
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-16
STERLING BIOTECH
Dec-13
ALKEM LABORATORIES/
STERLING BIOTECH
5-Yr Chart
Click to enlarge
High Rs1,58911 15,133.3%   
Low Rs1,2323 36,235.3%   
Sales per share (Unadj.) Rs417.526.8 1,557.3%  
Earnings per share (Unadj.) Rs56.3-15.0 -376.4%  
Cash flow per share (Unadj.) Rs64.7-5.5 -1,184.5%  
Dividends per share (Unadj.) Rs12.700-  
Dividend yield (eoy) %0.90-  
Book value per share (Unadj.) Rs292.954.9 533.8%  
Shares outstanding (eoy) m119.57267.87 44.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.40.3 1,303.2%   
Avg P/E ratio x25.1-0.5 -5,392.1%  
P/CF ratio (eoy) x21.8-1.3 -1,713.4%  
Price / Book Value ratio x4.80.1 3,802.3%  
Dividend payout %22.60-   
Avg Mkt Cap Rs m168,6531,862 9,059.1%   
No. of employees `000NA1.4 0.0%   
Total wages/salary Rs m9,171547 1,677.3%   
Avg. sales/employee Rs ThNM5,303.3-  
Avg. wages/employee Rs ThNM403.8-  
Avg. net profit/employee Rs ThNM-2,959.0-  
INCOME DATA
Net Sales Rs m49,9157,181 695.1%  
Other income Rs m1,64543 3,861.7%   
Total revenues Rs m51,5617,223 713.8%   
Gross profit Rs m8,482947 895.8%  
Depreciation Rs m1,0062,543 39.5%   
Interest Rs m6714,377 15.3%   
Profit before tax Rs m8,451-5,931 -142.5%   
Minority Interest Rs m-1140-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,606-1,924 -83.5%   
Profit after tax Rs m6,731-4,007 -168.0%  
Gross profit margin %17.013.2 128.9%  
Effective tax rate %19.032.4 58.6%   
Net profit margin %13.5-55.8 -24.2%  
BALANCE SHEET DATA
Current assets Rs m27,06214,335 188.8%   
Current liabilities Rs m15,32449,809 30.8%   
Net working cap to sales %23.5-494.0 -4.8%  
Current ratio x1.80.3 613.6%  
Inventory Days Days67403 16.5%  
Debtors Days Days41171 24.2%  
Net fixed assets Rs m12,61055,432 22.7%   
Share capital Rs m239268 89.2%   
"Free" reserves Rs m34,49013,935 247.5%   
Net worth Rs m35,02714,701 238.3%   
Long term debt Rs m1,2129,478 12.8%   
Total assets Rs m54,38773,988 73.5%  
Interest coverage x13.6-0.4 -3,832.0%   
Debt to equity ratio x00.6 5.4%  
Sales to assets ratio x0.90.1 945.7%   
Return on assets %13.60.5 2,717.1%  
Return on equity %19.2-27.3 -70.5%  
Return on capital %24.9-6.4 -386.8%  
Exports to sales %12.925.9 50.0%   
Imports to sales %3.10.2 1,816.3%   
Exports (fob) Rs m6,4611,860 347.4%   
Imports (cif) Rs m1,54012 12,625.4%   
Fx inflow Rs m6,5631,860 352.9%   
Fx outflow Rs m3,01225 12,100.0%   
Net fx Rs m3,5521,835 193.6%   
CASH FLOW
From Operations Rs m7,2591,719 422.3%  
From Investments Rs m1,864-3,148 -59.2%  
From Financial Activity Rs m-9,2731,426 -650.3%  
Net Cashflow Rs m-150-3 4,411.8%  

Share Holding

Indian Promoters % 66.9 33.9 197.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 33.1 0.0 -  
FIIs % 0.0 9.9 -  
ADR/GDR % 0.0 16.9 -  
Free float % 0.0 39.3 -  
Shareholders   68,381 21,482 318.3%  
Pledged promoter(s) holding % 0.0 55.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   WOCKHARDT LTD.  J.B.CHEMICALS  MERCK LTD  DIVIS LABORATORIES  FULFORD INDIA  

Compare ALKEM LABORATORIES With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades in Green; Lupin up 4%(01:30 pm)

After opening the day flat, share markets in India remained rangebound and are presently trading marginally above the dotted line.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

Dear PM Modi, India is Already Land of Self-Employed, and It Ain't Working(Vivek Kaul's Diary)

Aug 21, 2017

Most Indians who cannot find jobs, look at becoming self-employed.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

Think Twice Before You Keep Money In A Savings Bank Account(Outside View)

Aug 22, 2017

Post demonetisation, a cut in bank savings deposits rates was in the offing.

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


Aug 24, 2017 02:41 PM

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES - PANACEA BIOTECH COMPARISON

COMPARE ALKEM LABORATORIES WITH

MARKET STATS